Healthcare - Biotechnology - NASDAQ - US
$ 6.175
-10.6 %
$ 1.73 B
Market Cap
-4.23
P/E
INCOME STATEMENT
44.6 M
REVENUE
-350 M
OPERATING INCOME
-328 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Recursion Pharmaceuticals, Inc.
| Revenue | 44.6 M |
| Cost Of Revenue | 42.6 M |
| Gross Profit | 1.99 M |
| Operating Expenses | 352 M |
| Operating Income | -350 M |
| Other Expenses | -22 M |
| Net Income | -328 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 44.6 | 39.7 | 10.0 | 3.4 | 1.7 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 42.6 | 48.3 | 9.1 | 63.3 | 45.8 |
| Gross Profit | 2.0 | (8.6) | 0.9 | (59.9) | (44.1) |
| OPERATING INCOME | |||||
| Operating Expenses | 352.0 | 237.1 | 192.8 | 88.0 | 64.2 |
| Selling, General and Administrative Expenses | 110.8 | 81.6 | 57.7 | 25.3 | 19.0 |
| Research and Development Expenses | 241.2 | 155.7 | 135.3 | 63.3 | 45.8 |
| Operating Income | (350.1) | (245.7) | (182.8) | (84.6) | (62.4) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 97 K | 55 K | 3.0 | 1.4 | 0.6 |
| Total Other Income | 17.9 | 6.3 | (3.7) | (2.4) | 0.6 |
| Pre-Tax Income | (332.1) | (239.5) | (186.5) | (87.0) | (61.9) |
| NET INCOME | |||||
| Tax Provision | (4.1) | 55 K | (8.4) | 0.9 | 0.6 |
| Net Income | (328.1) | (239.4) | (178.1) | (87.9) | (62.5) |
| EPS | 1.58 | 1.36 | 1.05 | 0.525 | 0.373 |